This is a working overview of preclinical research, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-11-24 and is reviewed periodically as new material appears.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
Reported effects of dihexa are often described in terms of synaptogenesis, a process by which neurons form new synaptic connections. This concept is biologically plausible but difficult to measure directly in living humans. Animal behavioral tests can suggest memory or learning changes, yet such tests have limitations and may not translate to people. The literature includes conflicting or incomplete findings, and some studies are small. As a result, the mechanism remains a subject of investigation rather than a settled explanation.
The proposed mechanism of dihexa involves activation of hepatocyte growth factor and its receptor, c-Met. In cell models, this signaling pathway is associated with dendritic spine formation and synaptic reorganization. Dihexa is described as a stabilized analog of angiotensin IV, which also interacts with related systems. However, the precise binding profile and downstream effects remain incompletely characterized. Most mechanistic evidence comes from in vitro assays and rodent studies rather than human trials.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
| Property | Value | Notes |
|---|---|---|
| Common name | Dihexa | Shorthand used in research literature and supplier catalogs. |
| CAS Registry Number | 1401708-83-5 | Identifier assigned to the synthetic peptide. |
| Molecular formula | C27H44N4O5 | Reported formula; verify with a certificate of analysis. |
| Appearance | White to off-white powder | Typical form for lyophilized research peptides. |
| Typical storage | −20 °C or below, desiccated | Common condition for peptide stability. |
Animal studies have examined dihexa in models of cognitive impairment, synaptic plasticity, and memory. Some reports describe improved performance on maze or avoidance tasks after administration. These findings are preclinical and often involve small samples, varied routes, and differing formulations. Results in rodents do not establish effects in humans. The absence of published randomized controlled trials in people is a major gap in the evidence base. Observational reports and user accounts do not substitute for controlled clinical data.
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.
Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.
Regulatory agencies have not approved dihexa as a prescription drug or supplement. In many countries it falls into a gray area when sold for laboratory research. Buyers may encounter products marketed for research use only, which are not intended for human consumption. Purity and identity can vary between suppliers and batches. Certificates of analysis and independent testing are often recommended for research materials. Documentation helps verify what a vial contains.
The angiotensin IV connection places dihexa in a family of short peptides studied for effects on central nervous system signaling. Angiotensin IV itself is a metabolite of angiotensin II, and analogs have been explored in cardiovascular and neurological research. Dihexa differs from the natural peptide through structural modifications intended to alter stability and receptor interactions. Published descriptions sometimes call it a hepatocyte growth factor mimetic, although that label reflects proposed activity rather than a confirmed clinical mechanism.
Identity checks for dihexa usually rely on mass spectrometry and chromatographic purity analysis. A lyophilized powder is the common supplied form, and it may appear as a white to off-white solid. Aqueous solubility is limited, so laboratory work often uses an organic solvent such as dimethyl sulfoxide to prepare stock solutions. Because the peptide is not a standard pharmaceutical product, exact specifications can vary between suppliers. Certificates of analysis may accompany a batch, but they are not equivalent to regulatory approval.
Dihexa is a synthetic peptide whose structure is modeled on angiotensin IV. Its chemical name often appears as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, though vendor and publication naming can differ. The molecule combines a short amino acid sequence with a hexanoic acid group and an amide terminus. It is classed as a small research peptide rather than a conventional drug. Databases may list it under several synonyms, so matching names are important when comparing sources.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
==== Biological control ==== The EPA of New Zealand approved the release of Limenitis glorifica butterflies in 2013 as a biological control for Lonicera japonica. This butterfly is host specific for Japanese honeysuckle, but it may incidentally feed on other closely related plants, including Himalayan honeysuckle Leycesteria formosa. Oberea shirahatai is a Japanese honeysuckle host-specific beetle that feeds on the stems and leaves of Japanese honeysuckle. It was released in New Zealand in 2018 as another L. japonica-specialist biological control.
In February 1968, ruling on Madzimbamuto's appeal, Beadle concluded that the Smith administration would be recognised by the local judiciary as the de facto government by virtue of its "effective control over the state's territory", but that de jure recognition would be withheld as this was not "firmly established". Madzimbamuto applied for the right to appeal to the British Privy Council; the Rhodesian Appellate Division promptly ruled that he had no right to do so, but the Privy Council considered his case anyway. In late February 1968, considering the fate of James Dhlamini, Victor Mlambo and Duly Shadreck, three black Rhodesians convicted of murder and terrorist offences before UDI, Beadle ruled that Salisbury retained its pre-UDI powers regarding executions and could carry out death sentences. Whitehall announced on 1 March that at the request of the UK government, the Queen had exercised the royal prerogative of mercy and commuted the three death sentences to life imprisonment. Dhlamini and the others applied for a permanent stay of execution on this basis. At the hearing for Dhlamini and Mlambo on 4 March 1968, Beadle argued that he saw the statement from London as a decision by the UK government and not the Queen herself, and that in any case the 1961 constitution had transferred the prerogative of mercy from Britain to the Rhodesian Executive Council. "The present government is the fully de facto government and as such is the only power that can exercise the prerogative", he concluded.
== Pollution tolerance == Xanthoria parietina is highly resistant to air pollution, including heavy metals, nitrogen compounds, and ozone. Laboratory experiments have shown that it tolerates exposure to air contaminants and bisulfite ions with little or no damage. It is also resistant to heavy metal contamination and nitrogen pollution. The mechanisms underlying this tolerance involve multiple protective systems. The parietin layer in the upper cortex acts as a hydrophobic barrier, reducing the penetration of toxic metal ions into the photobiont cells. Experimental studies have shown that parietin-deficient thalli experience greater physiological stress when exposed to heavy metals. Parietin also contributes to ozone tolerance; fumigation experiments revealed that samples containing parietin recovered photosynthetic efficiency and chlorophyll integrity more quickly than those without it, suggesting an antioxidant function in addition to its role as a light-screening pigment. Furthermore, reactive oxygen species (ROS) levels induced by ozone exposure were significantly higher in parietin-deficient samples, reinforcing its role in oxidative stress mitigation. The hydration state of X. parietina influences its ozone sensitivity. Dry thalli suffer less damage and recover more quickly than hydrated ones, likely because reduced gas exchange limits ozone penetration. This factor helps explain the lichen's resilience in Mediterranean climates, where it often remains desiccated during periods of high ozone pollution.
== Alternatives == RGD is the most widely used of a larger class of cell adhesive peptides. These short amino acid sequences are the minimum motif of a larger protein that is necessary for binding to a cell surface receptor that drives cell adhesion. The majority (89%) of published studies on biomaterials functionalized with cell adhesive peptides use RGD, whereas IKVAV and YIGSR are used in 6%, and 4% of those studies, respectively. Cell adhesive peptides isolated from fibronectin include RGD, RGDS, PHSRN, and REDV. YIGSR and IKVAV are isolated from laminin, whereas DGEA and GFOGER/GFPGER are isolated from collagen. Artificial amino acid sequences, which bear no biological similarity to ECM proteins, have also been synthesized, and include the α5β1-specific peptide RRETAWA.
San Donato district is between Corso Francia, Corso Lecce, Corso Potenza, Via Nole, the Parco Dora and Corso Principe Oddone. It was populated since the medieval era, but becomes bigger during the 19th century, prospering around the canal Canale di San Donato, which does not exist anymore, currently replaced by the central street of the district, Via San Donato. Buildings in the district are relatively recent (around 1820), except for the oldest group of small houses in the Brusachœr neighbourhood (Palazzo Forneris building) along Via Pacinotti near the small Piazza Paravia. The conservation of the street and of this old building influences the straightness of Via San Donato, which makes a slight curve to result in parallel with Via Pacinotti before ending in central Piazza Statuto square. Main church of the district is the Chiesa di Nostra Signora del Suffragio e Santa Zita, which with its 83 m (272 ft) height of its bell tower, is well known to be the fifth tallest structure in the city of Turin, after the Mole Antonelliana, the Intesa-Sanpaolo skyscraper, the Torre Littoria and the two pennons of the Juventus Stadium. The church is hosting the Istituto Suore Minime di Nostra Signora del Suffragio and it was promoted and designed by Francesco Faà di Bruno. The legend says, that he wanted to build the tallest bell tower of the town and put a clock on the top, to all the poor people to know the time for free. The small building near the church is what remains of Casa Tartaglino, a small residential building which was also extended and modified by Faa di Bruno.
Sources: en.wikipedia.org
== Aims == Xenobiology has the potential to reveal fundamental knowledge about biology and the origin of life. In order to better understand the origin of life, it is necessary to know why life evolved seemingly via an early RNA world to the DNA-RNA-protein system and its nearly universal genetic code. Was it an evolutionary "accident" or were there constraints that ruled out other types of chemistries? By testing alternative biochemical "primordial soups", it is expected to better understand the principles that gave rise to life as we know it. Xenobiology is an approach to develop industrial production systems with novel capabilities by means of biopolymer engineering and pathogen resistance. The genetic code encodes in all organisms 20 canonical amino acids that are used for protein biosynthesis. In rare cases, special amino acids such as selenocysteine or pyrrolysine can be incorporated by the translational apparatus into the proteins of some organisms. Together, these 20+2 Amino Acids are known as the 22 Proteinogenic Amino Acids. By using additional amino acids from among the over 700 known to biochemistry, the capabilities of proteins may be altered to give rise to more efficient catalytical or material functions. The EC-funded project Metacode, for example, aims to incorporate metathesis (a useful catalytical function so far not known in living organisms) into bacterial cells. Xenobiology could also potentially improve production processes by reducing the risk of viral or bacteriophage contamination in cultivations.
List of New York City Designated Landmarks in Manhattan from 14th to 59th Streets List of New York City parks List of New York City scenic landmarks National Register of Historic Places listings in Manhattan from 14th to 59th Streets
==== Structural abnormalities ==== Hemoglobin structural variants manifest a change in the structure of the Hb molecule. The majority of hemoglobin variants do not cause disease and are most commonly discovered either incidentally or through newborn screening. Hb variants can usually be detected by protein-based assay methods such as electrophoresis, isoelectric focusing, or high-performance liquid chromatography. Diagnosis is commonly confirmed by DNA sequencing. The hemoglobin structural variants can be broadly classified as follows:
In September 2020, an in vitro and in vivo study found that DMT present in the ayahuasca infusion promotes neurogenesis. DMT has been found to be a psychoplastogen, a compound capable of promoting rapid and sustained neuroplasticity that may have wide-ranging therapeutic benefit. The cryo-EM structures of the serotonin 5-HT2A receptor with DMT, as well as with various other psychedelics and serotonin 5-HT2A receptor agonists, have been solved and published by Bryan L. Roth and colleagues.
Sources: en.wikipedia.org
One example, in which both plant and animal alkanes play a role, is the ecological relationship between the sand bee (Andrena nigroaenea) and the early spider orchid (Ophrys sphegodes); the latter is dependent for pollination on the former. Sand bees use pheromones in order to identify a mate; in the case of A. nigroaenea, the females emit a mixture of tricosane (C23H48), pentacosane (C25H52) and heptacosane (C27H56) in the ratio 3:3:1, and males are attracted by specifically this odor. The orchid takes advantage of this mating arrangement to get the male bee to collect and disseminate its pollen; parts of its flower not only resemble the appearance of sand bees but also produce large quantities of the three alkanes in the same ratio as female sand bees. As a result, numerous males are lured to the blooms and attempt to copulate with their imaginary partner: although this endeavor is not crowned with success for the bee, it allows the orchid to transfer its pollen, which will be dispersed after the departure of the frustrated male to other blooms.
McKew said that "Putin and his minions have spent the past 15 years ranting about how the West (specifically NATO) wants a new Cold War". She suggested that "fighting a new Cold War would be in America's interest", adding "We won the last Cold War. We will win the next one too". The New Republic editor Jeet Heer criticised McKew's suggestion as "troubling" and for "wildly overstating the extent of Russian ambitions and power". Heer said that unlike the old Cold War, "Current U.S. troubles with Russia aren't the result of ideological differences ... and are intensely localized along Russia's borders, in countries like the Ukraine and Georgia". Jeremy Shapiro, a senior fellow in the Brookings Institution, wrote in his blog post at RealClearPolitics, referring to the US–Russia relations: "A drift into a new Cold War has seemed the inevitable result" of "Russian–Western confrontation" over Eastern European counties such as Ukraine, Moldova and Georgia. In August 2017, Russian Deputy Foreign Minister Sergei Ryabkov denied claims that the US and Russia were having another cold war, despite ongoing tensions between the two countries over Ukraine and Syria, and newer US sanctions against Russia. The University of East Anglia graduate student Oliver Steward, as well as the Casimir Pulaski Foundation senior fellow Stanisław Koziej, attributed the Russia's Zapad 2017 exercise in Belarus as part of the new Cold War between Russia and the West.
=== Semi-moist === Semi-moist dog food is packaged in vacuum-sealed pouches or packets. It contains about 20–45% water by weight, making it more expensive per energy calorie than dry food. Most semi-moist food does not require refrigeration. They are lightly cooked and then quickly sealed in a vacuum package. This type of dog food is extremely vulnerable to spoiling if not kept at a cool temperature and has a shelf life of 2–4 months, unopened.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide modeled on angiotensin IV. It is used in laboratory and animal research, not as an approved medicine. Human effects remain poorly characterized.
It is produced by chemical synthesis, not extracted from plants or animals. Its design is based on a naturally occurring peptide fragment. Suppliers sell it as a research chemical.
No, dihexa is a modified analog of angiotensin IV. The two share a structural relationship but differ in chemical details. Research on one does not automatically apply to the other.
Dihexa has been reported to activate hepatocyte growth factor/c-Met signaling in cell studies. This pathway is linked to synapse formation and neuronal remodeling. The exact molecular interactions are not fully understood.